Stavudine
- Product NDC
- 31722-515
- 11-digit product format
- 317220515
- Labeler code
- 31722
- Product ID
- 31722-515_47401c88-8cae-4352-9942-94fbc43e856a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Stavudine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA078957
- Marketing category
- ANDA
- Marketing start
- 2008-12-29
- Marketing end
- 0000-00-00
- Substance
- STAVUDINE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 31722-515-01 | 2023-08-10 | C162847 | 48780-1 | 9d75b9d0-7cc6-f424-e053-dadaa90a57ce | 12cbb604-d5f8-49ee-962c-bb12f4105bb3 |
| 31722-515-10 | 2023-08-10 | C162847 | 48780-1 | 9d75b9d0-7cc6-f424-e053-dadaa90a57ce | 12cbb604-d5f8-49ee-962c-bb12f4105bb3 |
| 31722-515-60 | 2023-08-10 | C162847 | 48780-1 | 9d75b9d0-7cc6-f424-e053-dadaa90a57ce | 12cbb604-d5f8-49ee-962c-bb12f4105bb3 |
| 31722-515-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7cc6-f424-e053-dadaa90a57ce | 12cbb604-d5f8-49ee-962c-bb12f4105bb3 |
| 31722-515-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7cc6-f424-e053-dadaa90a57ce | 12cbb604-d5f8-49ee-962c-bb12f4105bb3 |
| 31722-515-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7cc6-f424-e053-dadaa90a57ce | 12cbb604-d5f8-49ee-962c-bb12f4105bb3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 31722-515-60 | EA - Each | 31722-515 | 44d06d76-e033-4c1d-bfbf-672c06fd1c1b | 1 | 2012-07-24 |